Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 3 · 100%High 0 · 0%

H. pylori persistence, PCA subgroup · patients with Helicobacter pylori infection

PPI triple therapy for 10 days probably leads to lower H. pylori persistence, PCA subgroup compared with 7 days (moderate certainty).

1 finding from 1 review

Optimum duration of regimens for Helicobacter pylori eradication 2013 · Cochrane Headline outcomes only
RR 0.8 [0.7, 0.91]
17 studies · 3271 participants
Moderate

H. pylori persistence, PCA subgroup · patients with Helicobacter pylori infection

PPI triple therapy for 14 days probably leads to lower H.pylori persistence, PCA subgroup compared with 10 days (moderate certainty).

1 finding from 1 review

Optimum duration of regimens for Helicobacter pylori eradication 2013 · Cochrane Headline outcomes only
RR 0.69 [0.52, 0.91]
10 studies · 1596 participants
Moderate

H. pylori persistence, PCA subgroup · patients with Helicobacter pylori infection

PPI triple therapy for 14 days probably leads to lower H. pylori persistence, PCA subgroup compared with 7 days (moderate certainty).

1 finding from 1 review

Optimum duration of regimens for Helicobacter pylori eradication 2013 · Cochrane Headline outcomes only
RR 0.65 [0.57, 0.75]
34 studies · 5801 participants
Moderate